|
Index of reports
> Cases resulting in a serious event (30)
Below is the selection of adverse event reports related to Septra (Trimethoprim / Sulfamethoxazole) that includes cases resulting in a serious event.
Reports 1 - 25 of 30 Next >>
Adverse event in male receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-31
Patient: male, weighing 108.9 kg (239.5 pounds)
Adverse reactions / side effects: Tendon Rupture, Injury
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Cipro
Dosage: 500mg bid po x 7 days
Administration route: Oral
Indication: Prostatomegaly
Start date: 1999-08-01
Cipro
Dosage: 500mg bid po x 7 days
Administration route: Oral
Indication: Urinary Tract Infection
Start date: 1999-08-01
Cipro
Dosage: 500mg bid po x 21 days
Administration route: Oral
Indication: Prostatitis
Start date: 2001-03-01
Cipro
Dosage: 500 bid x 21 days
Indication: Prostatitis
Start date: 1999-08-12
Septra
Dosage: bid
Start date: 1999-07-20
End date: 1999-07-29
Adverse event in receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a physician from United Kingdom on 2007-10-26
Patient:
Adverse reactions / side effects: Microcytic Anaemia
Suspect drug(s):
Combivir
Dosage: 1 tablet, qd
Indication: Prophylaxis Against HIV Infection
Nevirapine
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Septra
Adverse event in receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient:
Adverse reactions / side effects: Anaemia
Suspect drug(s):
Combivir
Dosage: 150/300 mg
Indication: Prophylaxis Against HIV Infection
Kaletra
Dosage: 50 mg/200 mg
Indication: Prophylaxis Against HIV Infection
Lamivudine
Dosage: 10 mg/ml, unk
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Lamivudine
Dosage: 150 mg, unk
Nelfinavir Mesilate
Dosage: unk, unk
Indication: Prophylaxis Against HIV Infection
Nevirapine
Dosage: 50 mg/ml, unk
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Nevirapine
Dosage: 200 mg, unk
Septra
Stavudine
Indication: Prophylaxis Against HIV Infection
Zidovudine
Dosage: 10 mg/ml, unk
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Adverse event in female receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a health professional (non-physician/pharmacist) from Canada on 2007-10-01
Patient: female
Adverse reactions / side effects: Jaundice, Renal Failure, Hepatic Enzyme Increased
Adverse event resulted in: death
Suspect drug(s):
Screening Phase (Screening Phase)
Indication: Drug USE FOR Unknown Indication
Septra
Adverse event in 43 year old female receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a physician from United States on 2007-07-25
Patient: 43 year old female, weighing 84.4 kg (185.6 pounds)
Adverse reactions / side effects: Incision Site Pain, Cellulitis, Febrile Neutropenia, Abscess
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 0.48 ml; qw; sc
Indication: Hepatitis C
Start date: 2006-02-03
End date: 2007-01-04
Rebetol
Dosage: 1200 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-02-03
End date: 2007-01-04
Septra
Indication: Abscess
Start date: 2007-01-09
End date: 2007-01-28
Septra
Indication: Cellulitis
Start date: 2007-01-09
End date: 2007-01-28
Other drugs received by patient: Effexor; Prevacid; Phenergan HCL
Adverse event in 56 year old male receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a individual with unspecified qualification from United States on 2007-07-25
Patient: 56 year old male, weighing 69.9 kg (153.8 pounds)
Adverse reactions / side effects: Rash
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Adverse event in receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a consumer/non-health professional from Canada on 2007-07-13
Patient:
Adverse reactions / side effects: Dysmorphism, Multiple Congenital Abnormalities, Deafness Congenital, Limb Malformation, Urinary Tract Malformation, Spine Malformation, Ear Malformation, Grand MAL Convulsion, Congenital Anomaly
Suspect drug(s):
Efavirenz
Fluconazole
Methadone Hydrochloride
Nevirapine
Pentamidine Isethionate
Septra
Adverse event in receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a physician from Canada on 2007-07-12
Patient:
Adverse reactions / side effects: Dyspnoea, Mucosal Ulceration, Skin Exfoliation, Conjunctivitis, Pain, Depressed Level of Consciousness, Dermatitis Bullous, Pyrexia, Rash Maculo-Papular
Suspect drug(s):
Amoxicillin Trihydrate
Dosage: 500 mg, tid
Administration route: Oral
Azithromycin
Ceftriaxone Sodium
Clarithromycin
Dosage: 500 mg, bid
Erythromycin
Dosage: 333 mg, tid
Septra
Dosage: unk, bid
Administration route: Oral
Adverse event in receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a health professional (non-physician/pharmacist) from Turkey on 2007-06-29
Patient:
Adverse reactions / side effects: Vitamin B12 Decreased, Aspiration Bone Marrow Abnormal, Tachycardia, Anaemia, Pallor, Substance Abuse, Acute Lymphocytic Leukaemia, Blood Folate Decreased, Hepatomegaly, Fatigue, Anorexia, Blood Smear Test Abnormal, Splenomegaly, Thrombocytopenia
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Adverse event in 13 year old female receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a physician from Canada on 2007-06-29
Patient: 13 year old female
Adverse reactions / side effects: Dyspnoea, Mucosal Ulceration, Skin Exfoliation, Conjunctivitis, Pain, Depressed Level of Consciousness, Dermatitis Bullous, Pyrexia, Rash Maculo-Papular
Suspect drug(s):
Amoxil
Dosage: 500mg three times per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Azithromycin
Indication: Drug USE FOR Unknown Indication
Clarithromycin
Dosage: 500mg twice per day
Indication: Drug USE FOR Unknown Indication
Erythromycin
Dosage: 333mg three times per day
Indication: Drug USE FOR Unknown Indication
Rocephin
Indication: Drug USE FOR Unknown Indication
Septra
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a pharmacist from United States on 2007-06-29
Patient:
Adverse reactions / side effects: Brain Death, Confusional State, Nervous System Disorder, Brain Oedema, Delirium, CSF Protein
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Adverse event in 74 year old male receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a pharmacist from United States on 2007-06-20
Patient: 74 year old male
Adverse reactions / side effects: Myalgia, Dysstasia, Hyperkalaemia, Abasia, Muscular Weakness
Adverse event resulted in: hospitalization
Suspect drug(s):
Septra
Dosage: 1 tab bid po
Administration route: Oral
Indication: Cellulitis
Start date: 2007-06-01
End date: 2007-06-09
Septra
Dosage: 1 tab bid po
Administration route: Oral
Indication: Skin Infection
Start date: 2007-06-01
End date: 2007-06-09
Adverse event in 9 year old male receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-07
Patient: 9 year old male, weighing 45.4 kg (99.8 pounds)
Adverse reactions / side effects: Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Adverse event in 63 year old male receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a pharmacist from United States on 2007-05-29
Patient: 63 year old male
Adverse reactions / side effects: Electrocardiogram T Wave Peaked, Hyperkalaemia
Adverse event resulted in: life threatening event
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Other drugs received by patient: Amlodipine / Benazapril; Irebartan; Spironolactone
Adverse event in male receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a pharmacist from United States on 2007-05-15
Patient: male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: Secondary Syphilis, Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization
Suspect drug(s):
Doxycycline
Dosage: 100 mg po
Administration route: Oral
Indication: Secondary Syphilis
Start date: 2007-04-09
End date: 2007-04-23
Septra
Indication: Secondary Syphilis
Start date: 2007-04-10
End date: 2007-04-23
Adverse event in 50 year old male receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a physician from United States on 2007-04-26
Patient: 50 year old male, weighing 79.1 kg (174.0 pounds)
Adverse reactions / side effects: Drug Eruption, Lymphadenopathy, Skin Exfoliation, Drug Hypersensitivity, Penile Swelling, Groin Pain, Muscle Strain, Arthralgia, Rash Erythematous, Penis Disorder, Abscess, Purulent Discharge, Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Other drugs received by patient: Tylenol W / Codeine
Adverse event in 59 year old male receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a physician from United States on 2007-04-26
Patient: 59 year old male, weighing 104.3 kg (229.5 pounds)
Adverse reactions / side effects: Pruritus, Renal Failure Acute, Rash Macular
Adverse event resulted in: hospitalization
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Other drugs received by patient: Haldol; Terazosin HCL; Lorazepam; Metformin HCL; Atenolol; Simvastatin; Glyburide; Salsalate; Clopidogrel; Warfarin Sodium; Benztropine; Divalproex Sodium
Adverse event in 75 year old male receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a individual with unspecified qualification from United States on 2007-04-09
Patient: 75 year old male, weighing 129.7 kg (285.3 pounds)
Adverse reactions / side effects: Pruritus, Dyspnoea
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Adverse event in 62 year old male receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a individual with unspecified qualification from United States on 2007-04-06
Patient: 62 year old male, weighing 88.4 kg (194.5 pounds)
Adverse reactions / side effects: Nephritis Interstitial
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Adverse event in 80 year old male receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a individual with unspecified qualification from United States on 2007-04-06
Patient: 80 year old male, weighing 79.7 kg (175.3 pounds)
Adverse reactions / side effects: Rash
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Adverse event in receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a consumer/non-health professional from United States on 2007-04-05
Patient:
Adverse reactions / side effects: Productive Cough, Blood Bilirubin Increased, Hepatic Failure, Pyrexia, Prothrombin Time Prolonged, Idiosyncratic Drug Reaction, Cardiopulmonary Failure, Blood Creatinine Increased, Blood Alkaline Phosphatase Increased, Metabolic Alkalosis, Hypotension, Blood Lactate Dehydrogenase Increased, Chromaturia, Urine Bilirubin Increased, Hepatocellular Damage, Rash Erythematous, Aspartate Aminotransferase Increased, Rash Maculo-Papular, Jaundice, Hypersensitivity, Skin Exfoliation, Cholestasis, Abdominal Pain Upper, Hepatitis Cholestatic, Fatigue, Hepatomegaly, Gamma-Glutamyltransferase Increased, Thrombocytopenia, Splenomegaly, Oxygen Saturation Decreased, Vomiting, Alanine Aminotransferase Increased, Ascites, Acquired Diaphragmatic Eventration, Hypoalbuminaemia, Lung Infiltration, Leukopenia, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Adverse event in receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a consumer/non-health professional from Spain on 2007-03-29
Patient:
Adverse reactions / side effects: Pruritus, Vomiting, Nausea, Visual Acuity Reduced, Uveitis, Eye Pain, Conjunctival Hyperaemia, Vision Blurred
Suspect drug(s):
Bronquidiazina
Septra
Administration route: Oral
Indication: Nasopharyngitis
Septra
Dosage: unk, unk
Septra
Dosage: 5 ml, unk
Administration route: Oral
Adverse event in 39 year old female receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-12
Patient: 39 year old female, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Swelling Face, Dizziness, Rash
Suspect drug(s):
Atripla
Dosage: 1 in 1 d, oral
Administration route: Oral
Indication: HIV Infection
Start date: 2006-12-07
End date: 2006-12-22
Septra
Dosage: 1 in 1 d, oral
Administration route: Oral
Start date: 2006-12-07
End date: 2006-12-21
Adverse event in receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a consumer/non-health professional from United States on 2007-02-15
Patient:
Adverse reactions / side effects: Wheezing, Conjunctivitis, Lung Abscess, Dyspnoea Exertional, Multifocal Micronodular Pneumocyte Hyperplasia, Erythema Multiforme, Bronchiolitis, Stevens-Johnson Syndrome, Cough, Parainfluenzae Virus Infection, Eosinophilic Pneumonia, Rash, Mucosal Inflammation, Bronchiectasis, Rhonchi, Rash Erythematous, Epidermal Necrosis, Obstructive Airways Disorder, Rash Maculo-Papular
Suspect drug(s):
Septra (Trimethoprim / Sulfamethoxazole)
Adverse event in receiving Septra (Trimethoprim / Sulfamethoxazole)
Reported by a physician from Japan on 2007-02-07
Patient:
Adverse reactions / side effects: Haemoglobin Decreased, White Blood Cell Count Decreased, Haematocrit Decreased, Anaemia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Septra
Dosage: 1 tablet, qd
Administration route: Oral
Indication: Antifungal Prophylaxis
Start date: 2005-07-01
End date: 2005-07-11
Valganciclovir HCL
Dosage: 900 mg, bid
Administration route: Oral
Indication: Cytomegalovirus Enterocolitis
Start date: 2005-07-29
End date: 2005-08-18
Valganciclovir HCL
Dosage: 900 mg, qd
Start date: 2005-10-08
Zidovudine
Dosage: 400 mg, qd
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2005-07-01
End date: 2005-09-07
Other drugs received by patient: Lamivudine; Ritonavir; Kaletra; Atazanavir; Tenofovir Disoproxil Fumarate; Adenosine Triphosphate
Page 1 Next >>
|
